Apera has entered into an agreement with Universal Partners to provide debt facilities to support Dentex's refinancing and acquisition initiatives.

Information on the Target

Dentex is a prominent dental group that focuses on providing high-quality dental services and treatments across various locations. The company aims to enhance patient experience while expanding its service offerings through strategic acquisitions and innovative practices. With a dedicated team of professionals and a commitment to excellence, Dentex is poised to become a leading force in the dental industry.

This refinancing initiative aligns with Dentex's long-term growth strategy, enabling it to strengthen its financial foundation while pursuing potential acquisition opportunities that can further enhance its market presence.

Industry Overview in the Target’s Specific Country

The dental industry in the targeted country is experiencing significant growth, driven by increasing awareness of oral health and advancements in dental t

View Source

Similar Deals

European Investment Bank Xeltis

2025

Venture Debt Medical Devices & Implants Other
Corbel Capital Partners Skalar Pharma Holding LLC

2021

Venture Debt Proprietary & Advanced Pharmaceuticals Other
Hark Capital Pharos IV-A, L.P.

2025

Venture Debt Hospitals, Clinics & Primary Care Services United States of America
Unknown Aeon

2025

Other VC Medical & Diagnostic Laboratories Other
GOCA3 Technologie de mesure de fluidité membranaire

2025

Other VC Bio Diagnostics & Testing Other

Apera

invested in

Dentex

in

in a Venture Debt deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert